Neuropilin‐1 is not a marker of human Foxp3+ Treg P Milpied, A Renand, J Bruneau, DA Mendes‐Da‐Cruz, S Jacquelin, ... European journal of immunology 39 (6), 1466-1471, 2009 | 194 | 2009 |
CD155 on tumor cells drives resistance to immunotherapy by inducing the degradation of the activating receptor CD226 in CD8+ T cells M Braun, AR Aguilera, A Sundarrajan, D Corvino, K Stannard, S Krumeich, ... Immunity 53 (4), 805-823. e15, 2020 | 112 | 2020 |
CD8+ tumor-infiltrating T cells are trapped in the tumor-dendritic cell network A Boissonnas, F Licata, L Poupel, S Jacquelin, L Fetler, S Krumeich, ... Neoplasia 15 (1), 85-IN26, 2013 | 107 | 2013 |
CX3CR1 reduces Ly6Chigh-monocyte motility within and release from the bone marrow after chemotherapy in mice S Jacquelin, F Licata, K Dorgham, P Hermand, L Poupel, E Guyon, ... Blood, The Journal of the American Society of Hematology 122 (5), 674-683, 2013 | 85 | 2013 |
Jak2V617F and Dnmt3a loss cooperate to induce myelofibrosis through activated enhancer-driven inflammation S Jacquelin, J Straube, L Cooper, T Vu, A Song, M Bywater, E Baxter, ... Blood, The Journal of the American Society of Hematology 132 (26), 2707-2721, 2018 | 72 | 2018 |
Distinct effects of ruxolitinib and interferon-alpha on murine JAK2V617F myeloproliferative neoplasm hematopoietic stem cell populations RJ Austin, J Straube, C Bruedigam, G Pali, S Jacquelin, T Vu, J Green, ... Leukemia 34 (4), 1075-1089, 2020 | 46 | 2020 |
The anticancer effect of chaetocin is enhanced by inhibition of autophagy HJ Jung, I Seo, F Casciello, S Jacquelin, SW Lane, SI Suh, MH Suh, ... Cell death & disease 7 (2), e2098-e2098, 2016 | 38 | 2016 |
Murine models of myelofibrosis S Jacquelin, F Kramer, A Mullally, SW Lane Cancers 12 (9), 2381, 2020 | 24 | 2020 |
Targeting cell cycle and apoptosis to overcome chemotherapy resistance in acute myeloid leukemia VY Ling, J Straube, W Godfrey, R Haldar, Y Janardhanan, L Cooper, ... Leukemia 37 (1), 143-153, 2023 | 22 | 2023 |
Hematopoietic stem and progenitor cell-restricted Cdx2 expression induces transformation to myelodysplasia and acute leukemia T Vu, J Straube, AH Porter, M Bywater, A Song, V Ling, L Cooper, G Pali, ... Nature communications 11 (1), 3021, 2020 | 19 | 2020 |
Genome-wide transcription factor–binding maps reveal cell-specific changes in the regulatory architecture of human HSPCs S Subramanian, JAI Thoms, Y Huang, P Cornejo-Páramo, FC Koch, ... Blood 142 (17), 1448-1462, 2023 | 15 | 2023 |
Acute myeloid leukemia stem cell function is preserved in the absence of autophagy AH Porter, L Leveque-El Mouttie, T Vu, C Bruedigam, J Sutton, ... haematologica 102 (9), e344, 2017 | 13 | 2017 |
Oncogenic drivers dictate immune control of acute myeloid leukemia RJ Austin, J Straube, R Halder, Y Janardhanan, C Bruedigam, ... Nature Communications 14 (1), 2155, 2023 | 9 | 2023 |
Jak2V617F driven myeloproliferative neoplasm occurs independently of interleukin-3 receptor beta common signaling T Vu, R Austin, CP Kuhn, C Bruedigam, A Song, S Guignes, S Jacquelin, ... haematologica 101 (3), e77, 2016 | 9 | 2016 |
CRISPR-Cas13d screens identify KILR, a breast cancer risk-associated lncRNA that regulates DNA replication and repair L Wang, M Bitar, X Lu, S Jacquelin, S Nair, H Sivakumaran, KM Hillman, ... Molecular Cancer 23 (1), 101, 2024 | 5 | 2024 |
Systemic complement activation influences outcomes after allogeneic hematopoietic cell transplantation: A prospective French multicenter trial AB Notarantonio, M d'Aveni‐piney, S Pagliuca, Y Ashraf, JE Galimard, ... American Journal of Hematology 98 (10), 1559-1570, 2023 | 3 | 2023 |
Distinct roles of SOX9 in self-renewal of progenitors and mesenchymal transition of the endothelium J Zhao, L Sormani, S Jacquelin, H Li, C Styke, C Zhou, J Beesley, L Oon, ... Angiogenesis, 1-16, 2024 | 2 | 2024 |
Oncogenic-drivers dictate immune responses to control disease progression in acute myeloid leukaemia R Austin, M Bywater, J Straube, LT Cooper, M Headlam, K Dave, M Braun, ... Blood, The Journal of the American Society of Hematology 132 (Supplement 1 …, 2018 | 1 | 2018 |
Prognostic Significance of Complement System Activation After Allogeneic Hematopoietic Stem Cell Transplantation. MT Rubio, MA Durey-Dragon, Y Wang, J Blouin, S Jacquelin, P Milpied, ... Blood 114 (22), 1166, 2009 | 1 | 2009 |
Cell Type-Specific Regulation by a Heptad of Transcription Factors in Human Hematopoietic Stem and Progenitor Cells S Subramanian, JAI Thoms, Y Huang, P Cornejo, FC Koch, S Jacquelin, ... bioRxiv, 2023.04. 18.537282, 2023 | | 2023 |